Cargando…
SAT-284 Sex Hormone Replacement Therapy in Turner Syndrome and the Impact on Morbidity and Mortality
Background: In Turner Syndrome (TS) it is recommended to induce puberty around 11-12 years of age, by initiating hormone replacement therapy (HRT), when premature ovarian failure is diagnosed. However, evidence for the long-term effects on morbidity and mortality is sparse and it is unknown how many...
Autores principales: | Viuff, Mette, Berglund, Agnethe, Juul, Svend, Andersen, Niels, Stochholm, Kirstine, Gravholt, Claus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552127/ http://dx.doi.org/10.1210/js.2019-SAT-284 |
Ejemplares similares
-
SAT-025 Increased Occurrence of Anemia, Gastrointestinal and Liver Diseases in Women with Turner Syndrome - a Nationwide Registry Study
por: Viuff, Mette Hansen, et al.
Publicado: (2020) -
SUN-225 The 47,XYY Syndrome Is Associated with Increased Morbidity: A Nationwide Registry Study
por: Berglund, Agnethe, et al.
Publicado: (2019) -
Changes in the cohort composition of turner syndrome and severe non-diagnosis of Klinefelter, 47,XXX and 47,XYY syndrome: a nationwide cohort study
por: Berglund, Agnethe, et al.
Publicado: (2019) -
Morbidity, mortality, and socioeconomics in Klinefelter syndrome and 47,XYY syndrome: a comparative review
por: Ridder, Lukas Ochsner, et al.
Publicado: (2023) -
Diagnosis and mortality in 47,XYY persons: a registry study
por: Stochholm, Kirstine, et al.
Publicado: (2010)